Cargando…
SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe
PURPOSE: The long-acting inhaled anticholinergic agent, tiotropium, is recommended as first-line maintenance therapy for moderate to very severe Chronic Obstructive Pulmonary Disease (COPD) to improve symptoms, exercise tolerance, health status, and to reduce exacerbations. Few studies have evaluate...
Autores principales: | Fležar, Matjaž, Jahnz-Różyk, Karina, Enache, Gloria, Martynenko, Tatiana, Kristufek, Peter, Škrinjarić-Cincar, Sanda, Kadlecová, Pavla, Martinovic, Goran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806120/ https://www.ncbi.nlm.nih.gov/pubmed/24159258 http://dx.doi.org/10.2147/COPD.S45640 |
Ejemplares similares
-
Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD – real-life experience from an observational study
por: Jahnz-Różyk, Karina, et al.
Publicado: (2015) -
A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2018) -
From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2020) -
An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD
por: Liang, Wen-Miin, et al.
Publicado: (2008) -
Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study
por: Freeman, Daryl, et al.
Publicado: (2007)